mGlu4 PAM for Parkinson’s disease

mGlu4 PAM for the treatment of Parkinson’s disease (PD).

We are developing mGlu4 PAM as a novel orally available treatment for Parkinson's disease. We are currently optimizing multiple chemical series of highly selective mGlu4 PAMs with compounds in early lead optimization.